http://weekly.chinacdc.cn/ China CDC Weekly cdcwjournal@163.com cdcwjournal@163.com en cdcwjournal@163.com 2096-7071 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.015?pageType=en Gabriel M Leung China CDC Weekly. 2019 1(4): 45-46. Gabriel M Leung China CDC Weekly. 2019 1(4): 45-46. Message from Deputy Editor-in-Chief Gabriel M Leung — International Trade and Global Health Protection Gabriel M Leung 2019-12-01 Personal use only, all commercial or other reuse prohibited China CDC Weekly. 2019 1(4): 45-46. article doi:10.46234/ccdcw2019.015 10.46234/ccdcw2019.015 China CDC Weekly 1 4 2019-12-01 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.015?pageType=en 45 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.016?pageType=en Shuaibing Dong, Xiang Ren, Cuihong Zhang, Mengjie Geng, Yuliang Zhu, Lusha Shi, Lijie Zhang, Zhongjie Li, Liping Wang <sec<<p< <b<What is already known about this topic?</b< </p< </sec<<sec<<p<Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (<span class="xref"<<a href="#b1" ref-type="bibr" data-href="#b1"<1</a<</span<,<span class="xref"<<a href="#b2" ref-type="bibr" data-href="#b2"<2</a<</span<).</p< </sec<<sec<<p< <b<What is added by this report?</b< </p< </sec<<sec<<p<In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region.</p< </sec< <sec<<p< <b<What are the implications for public health practice?</b< </p< </sec<<sec<<p<Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control.</p< </sec< China CDC Weekly. 2019 1(4): 47-53. Shuaibing Dong, Xiang Ren, Cuihong Zhang, Mengjie Geng, Yuliang Zhu, Lusha Shi, Lijie Zhang, Zhongjie Li, Liping Wang <sec<<p< <b<What is already known about this topic?</b< </p< </sec<<sec<<p<Annual morbidity analysis reports that summarized trends and changing epidemiology for notifiable diseases were published in 2013 and 2015 (<span class="xref"<<a href="#b1" ref-type="bibr" data-href="#b1"<1</a<</span<,<span class="xref"<<a href="#b2" ref-type="bibr" data-href="#b2"<2</a<</span<).</p< </sec<<sec<<p< <b<What is added by this report?</b< </p< </sec<<sec<<p<In 2018, the morbidity of national notifiable diseases was 559.41 per 100,000 population, an increase of 12.88% compared with the average rate between 2015–2017. The five notifiable diseases with the highest reported morbidity were hand, foot, and mouth disease (HFMD), infectious diarrhea, hepatitis B, tuberculosis, and influenza. The five regions with the highest reported morbidity of infectious diseases were Zhejiang Province, Guangxi Autonomous Region, Guangdong Province, Beijing Municipality, and Xinjiang Autonomous Region.</p< </sec< <sec<<p< <b<What are the implications for public health practice?</b< </p< </sec<<sec<<p<Evidence on notifiable disease morbidity trends and changing epidemiology should help disease control and prevention agencies and medical institutions direct their response and prevention efforts. In addition, this report demonstrates the continued need for surveillance systems and high-quality data to identify focal points for disease control.</p< </sec< China CDC Weekly. 2019 1(4): 47-53. Morbidity Analysis of the Notifiable Infectious Diseases in China, 2018 Shuaibing Dong, Xiang Ren, Cuihong Zhang, Mengjie Geng, Yuliang Zhu, Lusha Shi, Lijie Zhang, Zhongjie Li, Liping Wang 2019-12-01 Personal use only, all commercial or other reuse prohibited China CDC Weekly. 2019 1(4): 47-53. article doi:10.46234/ccdcw2019.016 10.46234/ccdcw2019.016 China CDC Weekly 1 4 2019-12-01 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.016?pageType=en 47 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.017?pageType=en Sheng Ding, Ying Xiong, Huanhong Pan, Zhongjian Li, Song Tang, Xingkui Huang, Jianxiong Li, Yong Shi, Weijie Fu, Huijian Cheng, Daping Che, Xiaoqing Liu, Wentao Song, Jingwen Wu, Yisheng zhou, Jian Zhang, Chao Li, Jiandong Li China CDC Weekly. 2019 1(4): 54-55. Sheng Ding, Ying Xiong, Huanhong Pan, Zhongjian Li, Song Tang, Xingkui Huang, Jianxiong Li, Yong Shi, Weijie Fu, Huijian Cheng, Daping Che, Xiaoqing Liu, Wentao Song, Jingwen Wu, Yisheng zhou, Jian Zhang, Chao Li, Jiandong Li China CDC Weekly. 2019 1(4): 54-55. Suspected Yellow Fever Case Determined to be Adverse Vaccine Reaction Sheng Ding, Ying Xiong, Huanhong Pan, Zhongjian Li, Song Tang, Xingkui Huang, Jianxiong Li, Yong Shi, Weijie Fu, Huijian Cheng, Daping Che, Xiaoqing Liu, Wentao Song, Jingwen Wu, Yisheng zhou, Jian Zhang, Chao Li, Jiandong Li 2019-12-01 Personal use only, all commercial or other reuse prohibited China CDC Weekly. 2019 1(4): 54-55. article doi:10.46234/ccdcw2019.017 10.46234/ccdcw2019.017 China CDC Weekly 1 4 2019-12-01 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.017?pageType=en 54 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.018?pageType=en Ran Zhang, Xiaoping Dong, Dayan Wang, Luzhao Feng, Lei Zhou, Ruiqi Ren, Carolyn Greene, Ying Song, Alexander J. Millman, Eduardo Azziz-Baumgartner, Zijian Feng <p<Almost 100 years after the 1918 influenza pandemic, China experienced its largest, most widespread epidemic of human infections with avian influenza A (H7N9), the influenza virus with the greatest pandemic potential of all influenza viruses assessed to date by the United States Centers for Disease Control and Prevention’s Influenza Risk Assessment Tool. This historical review describes how China was affected by the 1918, 1958, 1968, and 2009 influenza pandemics, records milestones in China’s capacity to detect and respond to influenza threats, and identifies remaining challenges for pandemic preparedness. This review suggests that past influenza pandemics have improved China’s national capabilities such that China has become a global leader in influenza detection and response. Further enhancing China’s pandemic preparedness to address remaining challenges requires government commitment and increased investment in China’s public health and healthcare systems.</p< China CDC Weekly. 2019 1(4): 56-61. Ran Zhang, Xiaoping Dong, Dayan Wang, Luzhao Feng, Lei Zhou, Ruiqi Ren, Carolyn Greene, Ying Song, Alexander J. Millman, Eduardo Azziz-Baumgartner, Zijian Feng <p<Almost 100 years after the 1918 influenza pandemic, China experienced its largest, most widespread epidemic of human infections with avian influenza A (H7N9), the influenza virus with the greatest pandemic potential of all influenza viruses assessed to date by the United States Centers for Disease Control and Prevention’s Influenza Risk Assessment Tool. This historical review describes how China was affected by the 1918, 1958, 1968, and 2009 influenza pandemics, records milestones in China’s capacity to detect and respond to influenza threats, and identifies remaining challenges for pandemic preparedness. This review suggests that past influenza pandemics have improved China’s national capabilities such that China has become a global leader in influenza detection and response. Further enhancing China’s pandemic preparedness to address remaining challenges requires government commitment and increased investment in China’s public health and healthcare systems.</p< China CDC Weekly. 2019 1(4): 56-61. One Hundred Years of Influenza Since the 1918 Pandemic — Is China Prepared Today? Ran Zhang, Xiaoping Dong, Dayan Wang, Luzhao Feng, Lei Zhou, Ruiqi Ren, Carolyn Greene, Ying Song, Alexander J. Millman, Eduardo Azziz-Baumgartner, Zijian Feng 2019-12-01 Personal use only, all commercial or other reuse prohibited China CDC Weekly. 2019 1(4): 56-61. article doi:10.46234/ccdcw2019.018 10.46234/ccdcw2019.018 China CDC Weekly 1 4 2019-12-01 http://weekly.chinacdc.cn/article/doi/10.46234/ccdcw2019.018?pageType=en 56

map